- Corporate Officers - P
- Passeri Daniel R
Insider Trading History of Passeri Daniel R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Passeri Daniel R since 2008.
This trader's CIK number is 1190121.
At the time of last reporting, Passeri Daniel R was the CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc.. (stock ticker symbol CUE).
Also see all insider trading activities at Cue Biopharma, Inc..
Note that in the past
PASSERI DANIEL R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Curis Inc (CRIS) by Passeri Daniel R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | CRIS | 0 | $0 | 0 | $0 | 12,900 | $20,253 |
| 2015 | CRIS | 0 | $0 | 377,100 | $1,114,276 | 377,100 | $592,047 |
| 2013 | CRIS | 0 | $0 | 175,000 | $645,050 | 377,667 | $917,730 |
| 2012 | CRIS | 25,000 | $75,750 | 110,650 | $533,359 | 171,400 | $214,582 |
| 2011 | CRIS | 0 | $0 | 125,000 | $406,788 | 125,000 | $391,250 |
| 2008 | CRIS | 20,000 | $31,000 | 0 | $0 | 20,000 | $21,800 |
Yearly summary of insider trading at Cue Biopharma, Inc. (CUE) by Passeri Daniel R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CUE | 30,000 | $30,900 | 0 | $0 | 0 | $0 |
| 2023 | CUE | 3,000 | $8,580 | 0 | $0 | 0 | $0 |
| 2022 | CUE | 0 | $0 | 0 | $0 | 75,000 | $0 |
| 2021 | CUE | 3,400 | $50,051 | 0 | $0 | 75,000 | $0 |
| 2019 | CUE | 4,377 | $30,697 | 0 | $0 | 0 | $0 |
| 2018 | CUE | 7,600 | $67,662 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Passeri Daniel R:
1. Curis Inc (CRIS)
2. Cue Biopharma, Inc. (CUE)
Table 1. Insider trading of Curis Inc (CRIS) by Passeri Daniel R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-06 | CRIS | Option Ex | 12,900 | 1.57 | 20,253 |
| 2015-12-29 | CRIS | Option Ex | 11,200 | 1.57 | 17,584 |
| 2015-12-30 | CRIS | Sale | 14,400 | 3.01 | 43,344 |
| 2015-12-29 | CRIS | Sale | 11,200 | 2.91 | 32,592 |
| 2015-12-30 | CRIS | Option Ex | 14,400 | 1.57 | 22,608 |
| 2015-12-24 | CRIS | Option Ex | 2,600 | 1.57 | 4,082 |
| 2015-12-24 | CRIS | Sale | 2,600 | 2.90 | 7,540 |
| 2015-12-28 | CRIS | Sale | 11,000 | 2.84 | 31,240 |
| 2015-12-28 | CRIS | Option Ex | 11,000 | 1.57 | 17,270 |
| 2015-12-23 | CRIS | Option Ex | 10,900 | 1.57 | 17,113 |
| 2015-12-22 | CRIS | Sale | 38,000 | 2.75 | 104,500 |
| 2015-12-23 | CRIS | Sale | 10,900 | 2.90 | 31,610 |
| 2015-12-22 | CRIS | Option Ex | 38,000 | 1.57 | 59,660 |
| 2015-12-21 | CRIS | Sale | 100,000 | 2.87 | 287,000 |
| 2015-12-18 | CRIS | Option Ex | 189,000 | 1.57 | 296,730 |
| 2015-12-18 | CRIS | Sale | 189,000 | 3.05 | 576,450 |
| 2015-12-21 | CRIS | Option Ex | 100,000 | 1.57 | 157,000 |
| 2013-05-06 | CRIS | Sale | 60,000 | 3.66 | 219,600 |
| 2013-05-06 | CRIS | Option Ex | 262,667 | 2.43 | 638,280 |
| 2013-05-03 | CRIS | Sale | 65,000 | 3.73 | 242,450 |
| 2013-05-02 | CRIS | Sale | 50,000 | 3.66 | 183,000 |
| 2013-05-02 | CRIS | Option Ex | 50,000 | 2.43 | 121,500 |
| 2013-05-03 | CRIS | Option Ex | 65,000 | 2.43 | 157,950 |
| 2012-12-06 | CRIS | Buy | 25,000 | 3.03 | 75,750 |
| 2012-04-30 | CRIS | Sale | 74,650 | 4.83 | 360,559 |
| 2012-05-01 | CRIS | Sale | 36,000 | 4.80 | 172,800 |
| 2012-04-30 | CRIS | Option Ex | 74,650 | 1.29 | 96,671 |
| 2012-05-01 | CRIS | Option Ex | 36,000 | 1.09 | 39,240 |
| 2012-03-20 | CRIS | Option Ex | 60,750 | 1.29 | 78,671 |
| 2011-03-30 | CRIS | Option Ex | 26,900 | 3.13 | 84,197 |
| 2011-03-31 | CRIS | Option Ex | 98,100 | 3.13 | 307,053 |
| 2011-03-30 | CRIS | Sale | 26,900 | 3.27 | 87,963 |
| 2011-03-31 | CRIS | Sale | 98,100 | 3.25 | 318,825 |
| 2008-10-01 | CRIS | Option Ex | 20,000 | 1.09 | 21,800 |
| 2008-08-07 | CRIS | Buy | 20,000 | 1.55 | 31,000 |
Table 2. Insider trading of Cue Biopharma, Inc. (CUE) by Passeri Daniel R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-16 | CUE | Buy | 30,000 | 1.03 | 30,900 |
| 2023-08-14 | CUE | Buy | 3,000 | 2.86 | 8,580 |
| 2022-03-31 | CUE | Option Ex | 75,000 | .00 | 0 |
| 2021-09-30 | CUE | Option Ex | 75,000 | .00 | 0 |
| 2021-09-24 | CUE | Buy | 3,400 | 14.72 | 50,051 |
| 2019-06-21 | CUE | Buy | 1,377 | 7.26 | 9,997 |
| 2019-06-06 | CUE | Buy | 3,000 | 6.90 | 20,700 |
| 2018-08-16 | CUE | Buy | 6,000 | 8.09 | 48,510 |
| 2018-06-29 | CUE | Buy | 1,600 | 11.97 | 19,152 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Passeri Daniel R
(CHIEF EXECUTIVE OFFICER of Cue Biopharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.